selenomethionine has been researched along with Acute Confusional Senile Dementia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Chen, Y; Ni, JZ; Song, GL; Wu, QY; Zhang, ZH; Zheng, R | 1 |
| Chen, C; Liu, Q; Ni, J; Shi, Q; Song, G; Wen, L; Zhang, Y; Zhang, Z | 1 |
| Chen, C; Hoffmann, PR; Liu, Q; Ni, JZ; Song, GL; Wu, QY; Zhang, ZH; Zheng, R | 1 |
| Chen, C; Chen, Y; Jia, SZ; Liu, Q; Ni, JZ; Song, GL; Zhang, ZH; Zheng, R | 1 |
| Chen, C; Chen, Y; Hoffmann, PR; Liu, Q; Ni, JZ; Song, GL; Wu, QY; Zhang, ZH; Zheng, R | 1 |
5 other study(ies) available for selenomethionine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Comparison of the effects of selenomethionine and selenium-enriched yeast in the triple-transgenic mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Brain; Cognition; Dietary Supplements; Disease Models, Animal; Humans; Mice; Mice, Transgenic; Saccharomyces cerevisiae; Selenium; Selenomethionine | 2018 |
Selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Cerebral Cortex; Cognition Disorders; Disease Models, Animal; Disks Large Homolog 4 Protein; Female; Glutathione; Glycogen Synthase Kinase 3; Guanylate Kinases; Hippocampus; Male; Membrane Proteins; Mice, Transgenic; Neuroglia; Neuroprotective Agents; Phosphorylation; Protein Phosphatase 2; Selenium; Selenomethionine; Synapses; Synaptophysin; tau Proteins | 2014 |
Selenomethionine reduces the deposition of beta-amyloid plaques by modulating β-secretase and enhancing selenoenzymatic activity in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Animals; Brain; Cells, Cultured; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Mice; Mice, Transgenic; Plaque, Amyloid; Selenomethionine; Selenoproteins | 2016 |
Selenomethionine promoted hippocampal neurogenesis via the PI3K-Akt-GSK3β-Wnt pathway in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Cell Proliferation; Cells, Cultured; Female; Glycogen Synthase Kinase 3 beta; Hippocampus; Male; Mice; Mice, Transgenic; Neural Stem Cells; Neurogenesis; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Selenomethionine; Signal Transduction; Wnt Signaling Pathway | 2017 |
Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Autophagy; Avoidance Learning; Brain; Cells, Cultured; Cognition Disorders; Enzyme Inhibitors; Gene Expression Regulation; Humans; Macrolides; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Nerve Tissue Proteins; Neurons; Presenilin-1; Reaction Time; Selenomethionine; tau Proteins | 2017 |